Trial intelligence / Profile preview

BlastX and TorrentX for Chronic Wound Biofilm

NCT03686904Phase 4Completed

Sponsor
Georgetown University
Start
Nov 2018
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of benzalkonium chloride in Wound infection (WI), sponsored by Georgetown University. Started Nov 2018; status: completed.

02

Drugs

benzalkonium chloride
03

Conditions

Wound infection (WI)

Beyond the preview

Go deeper on NCT03686904.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03686904.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call